Gene Query: KCTD18

Dataset Description Geneva Score
Transcriptome analysis of reticulated platelets reveals a prothrombotic profile 8.28
Transcriptome analysis of reticulated platelets reveals a prothrombotic profile [mRNA-Seq] 8.28
The transcriptomic landscape of MAIT cell development in the thymus (NN41 RNAseq data set) 4.34
HNRNPM-regulated splicing dependencies in prostate cancer [RNA-Seq] 4.12
HNRNPM-regulated splicing dependencies in prostate cancer 4.12
RNA expression in primary huamn muscle cells treated with 1,25(OH)2D3 or vehicle 3.42
mRNA and miRNA expression in primary human muscle cells treated with 1,25(OH)2D3 or vehicle 3.42
Suppression of ribosomal pausing by eIF5A is necessary to maintain the fidelity of start codon selection (RNA-sequencing) 3.38
Suppression of ribosomal pausing by eIF5A is necessary to maintain the fidelity of start codon selection 3.38
Nrf2 regulated genes in A549 cells 3.36
Identification of Nrf2 regulated genes by RNA sequencing 3.36
Lung adenocarcinoma metastasis is suppressed by the alveolar lineage transcription factors GATA6 and HOPX. 3.26
Tumors with TSC mutations are sensitive to CDK7 inhibition through NRF2 and glutathione depletion 3.18
Antibody-Mediated Inhibition of MICA/B Shedding Promotes NK Cell-Driven Tumor Immunity 3.15
Effect of digoxin treatment on the gene and alternative splice expression in human pluripotent stem cells- derived mesenchymal stem cells 3.04
The RNA binding protein IGF2BP3 promotes hematopoietic progenitor cell proliferation by targeting leukemogenic pathways 2.96
Tumor exosome integrins determine organotropic metastasis 2.87
4sU-seq of HFF exposed to salt and heat stress 2.83
Intrinsic histone acetyltransferase activity of BRD4 is responsible for nucleosome eviction and transcriptional activation 2.76
The evolution of N6-methyladenosine in primates 2.71
Multiple waves of transcriptome changes during extended hypoxic induction in human pulmonary microvascular endothelial cells 2.69
Epigenome regulation during epidermal lineage commitment [ATAC-seq, RNA-seq] 2.67
24hr CA treatment vs. DMSO in HCT116 cells (from 'Identification of CDK8 and CDK19 substrates in human cells using cortistatin A and quantitative phosphoproteomics') 2.66
Pharmacologic inhibition of STAT5 in AML 2.65
Molecular Hallmarks of Experimentally Acquired Immunity to Malaria [Pilot Study] 2.45
ADAR1 controls apoptosis of stressed cells by inhibiting Staufen-mediated mRNA decay 2.45
Enhancer Sequence Variants and Transcription Factor Deregulation Synergize to Construct Pathogenic Regulatory Circuits in B Cell Lymphoma (RNA-Seq) 2.44
Enhancer Sequence Variants and Transcription Factor Deregulation Synergize to Construct Pathogenic Regulatory Circuits in B Cell Lymphoma 2.44
A non-canonical role of YAP/TEAD is required for activation of estrogen-regulated enhancers in breast cancer [RNA-seq] 2.35
A non-canonical role of YAP/TEAD is required for activation of estrogen-regulated enhancers in breast cancer 2.35
RNA-seq analysis of control and NRDE2-depleted breast cancer cells 2.35
Global transcriptome analysis of HAP1 cells 2.28
IL-11 neutralising therapies for the treatment of nonalcoholic steatohepatitis 2.23
ONECUT2 Drives Neuroendocrine Prostate Cancer Through Hypoxia Signaling 2.16
Role for the Transcriptional Activator ZRF1 in Breast Cancer Progression and Endocrine Resistance 2.14
Apoptotic endothelial cells release small extracellular vesicles loaded with immunostimulatory viral-like RNAs 2.13
Gene expression in PANC1 cells treated with Rakicidin 2.1
Dual role of CSL (RBP-Jk) and NOTCH1 in cancer-associated fibroblast genome stability and expansion [RNA-seq] 2.1
Dual role of CSL (RBP-Jk) and NOTCH1 in CAF 2.1
BAF controls genome accessibility 2.07
Multiplexed engineering and analysis of endogenous enhancer activity in single cells: Mosaic-Seq of beta-globin locus (separate infection) 2.07
Reassessment of Exosome Composition 2.05
Migration through a small pore disrupts inactive chromatin organisation in neutrophil-like cells [RNA-seq] 2.04
RNA-seq and Hi-C sequencing of neutrophil-like cells migrated through large or small pores 2.04
Understanding the reproducibility and robustness of the kidney organoid differentiation protocol using RNA-seq 2.04
Expression level comparison under dividing and quiescent states in human primary fibroblasts 1.98
Integrative transcriptome-wide analyses reveal critical HER2-regulated mRNAs and lincRNAs in HER2+ breast cancer 1.93
Dynamic and stable enhancer-promoter contacts regulate terminal differentiation 1.93
Dynamic and stable enhancer-promoter contacts regulate terminal differentiation [RNA-Seq] 1.93
Gene expression profiling of leukemia cells following asparagine depletion 1.91
Tamoxifen Resistance in Breast Cancer is Regulated by the EZH2-ERa-GREB1 Transcriptional Axis 1.9
Host transcriptome analysis of Aspergillus fumigatus infection in Airway Epithelial Cells 1.89
Studying the selectivity of a targeted small molecule degrading a hypoxia-associated non-coding RNA 1.85
transcriptomic profiling of HEK293 cells upon individual knockdown of the splicing factors RBM17, U2SURP or CHERP 1.84
MLL-AF4 binds directly to a BCL-2 specific enhancer and impacts H3K27 acetylation 1.74
A faithful in vivo model of human MLL-AF4 proB acute lymphoblastic leukemia 1.71
Activation Dynamics and Immunoglobulin Evolution of Pre-existing and Newly Generated Human Memory B-cell Responses to Influenza Hemagglutinin 1.71
Global analysis of ZNF217 chromatin occupancy in the breast cancer cell genome reveals an association with Eralpha 1.66
RNA-seq differential expression studies: more sequence, or more replication? 1.65
Integrating single-cell transcriptomic data across different conditions, technologies, and species 1.57
Transcriptional control of subtype switching ensures adaptation and growth of pancreatic cancer 1.57
Targets of CDK12 on ZR-75-30 breast cancer cells (RNA-seq) 1.53
LncRNA expression profiling of ischemic stroke patients 1.51
MYC interacts with the G9a histone methyltransferase to drive transcriptional repression and tumorigenesis 1.5
The Developmental Heterogeneity of Human Natural Killer Cells Defined by Single-cell Transcriptome 1.49
Oncogenic MYC induces a dependency on the spliceosome in human cancer 1.49
SnapShot-Seq: a method for extracting genome-wide, in vivo mRNA dynamics from a single total RNA sample 1.49
RNA-seq data of small cell carcinoma of the bladder (SCCB) /urothelial carcinoma (Non-SCCB) clinical samples, and bladder-PARCB cell lines 1.49
Impeding transcription of expanded microsatellite repeats by deactivated Cas9 1.47
circRNA-sequencing 1.47
Gene expression profiling by RNA-seq in hTert-HME1 cell line treated with control or BRCA2 siRNAs and grown with or without EGF (epithelial growth factor) 1.46
Determination of a comprehensive alternative splicing regulatory network and the combinatorial regulation by key factors during Epithelial-to-Mesenchymal Transition [RBM47 KD] 1.46
Quantitative analysis of bi-modal binding of BET proteins at promoters predicts I-BET sensitivity 1.45
PolyA-sequencing in IMR-32 cells treated with THZ531 or DMSO 1.41
Overexpression of UGT2B17 in MEC1 and JVM2 leukemia cell lines 1.41
Transcriptional Regulationand Chromatin Dynamics inHuman Epithelial Cell Differentiation (RNA-seq) 1.39
Transcriptional Regulationand Chromatin Dynamics inHuman Epithelial Cell Differentiation 1.39
Transcriptome of EMT induced MCF10A cells by TGFb treatment or SNAIL S6A expression. 1.38
Coronary artery disease genes SMAD3 and TCF21 promote opposing interactive genetic programs that regulate smooth muscle cell differentiation and disease risk 1.38
Coronary artery disease genes SMAD3 and TCF21 promote opposing interactive genetic programs that regulate smooth muscle cell differentiation and disease risk [RNA-seq] 1.38
Hypertonic saline attenuates the cytokine-induced pro-inflammatory signature in primary human lung epithelia 1.37
Effect of CHKA knockdown on C4-2 cell transcriptome 1.37
The translation termination factor GSPT1 is a phenotypically relevant off-target of heterobifunctional phthalimide degraders 1.36
An optimization system for isolating and sequencing of single human colon cancer cells 1.34
RNA-seq in untreated and flagellin-treated Human Intestinal Myofibroblast cells (HIMF) 1.33
Bromodomain inhibition of the transcriptional coactivators CBP/EP300 as a therapeutic strategy to target the IRF4 network in multiple myeloma (RNA-Seq) 1.32
Bromodomain inhibition of the transcriptional coactivators CBP/EP300 as a therapeutic strategy to target the IRF4 network in multiple myeloma 1.32
An aspartyl protease defines a novel pathway for export of Toxoplasma proteins into the host cell 1.32
Loss of histone macroH2A1 in hepatocellular carcinoma cells promotes paracrine-mediated chemoresistance and CD4+CD25+ T regulatory cells activation 1.31
Cancer Associated Fibroblasts are defined by a core set of epigenome changes that contribute to the tumor phenotype 1.31
Cancer Associated Fibroblasts are defined by a core set of epigenome changes that contribute to the tumor phenotype [RNA-seq] 1.31
High-efficiency RNA-based reprogramming of human primary fibroblasts 1.28
Activation of PARP-1 by snoRNAs Controls Ribosome Biogenesis and Cell Growth via the RNA Helicase DDX21 (RNA-Seq) 1.28
Activation of PARP-1 by snoRNAs Controls Ribosome Biogenesis and Cell Growth via the RNA Helicase DDX21 1.28
RNA-seq analysis of activated plasmacytoid dendritic cell subsets after viral infection 1.27
Transcriptional profile of human STAT1-/- fibroblasts expressing LY6E or empty control vector 1.26
NSD2 overexpression links drives clustered chromatin and transcriptional changes in a subset of insulated domains of insulated domains 1.23
CD73 knockdown effect in pancreatic cancer cell lines 1.23
Che-1 is targeted by c-Myc to sustain proliferation in pre-B-cell acute lymphoblastic leukemia [RNA-seq] 1.23
Che-1 is targeted by c-Myc to sustain proliferation in pre-B-cell acute lymphoblastic leukemia 1.23
The Molecular Dissection of the Oncogenic Role of ETS1 in the Mesenchymal Subtypes of Head and Neck Squamous Cell Carcinoma [RNA-seq knock-down] 1.23
Single-cell transcriptomic analysis of tissue resident memory T cells in human lung cancer [ 10x genomics] 1.22
Genome-wide expression change by SHARPIN knockdown in MCF-7 cells 1.21
RNA-Seq analysis of 4N and 2N RPE1 cells following polyploid induction via cytokinesis failure or Aurora kinase inhibition [tpo3] 1.21
RNA-Seq analysis of JIB-04 effects on global cellular transcription and HIV in 2D10 T cells 1.21
mRNA-sequencing of 293T-no dice transfected with miR-16, miR-214, or KSHV-miR-K6-5p 1.21
Selective modulation of inflammatory Natural Killer (NK) cell phenotypes following histone H3K27 demethylase inhibition 1.2
Selective modulation of inflammatory Natural Killer (NK) cell phenotypes following histone H3K27 demethylase inhibition [RNA-Seq] 1.2
Gene expression profiling by RNA-seq in hTert-HME1 cell line treated with control or BRCA2 siRNAs and grown with or without EGF (epithelial growth factor) II 1.2
Identification of global regulators of T-helper cell lineage specification (RNA-Seq) 1.19
Identification of global regulators of T-helper cell lineage specification 1.19
Human iPSC-derived microglia assume a primary microglia-like state after transplantation into the neonatal mouse brain [Single Cell RNAseq] 1.19
RNAseq of PRMT4KD in human cord blood derived CD34+ cells 1.19
Activating PAX Gene Family Paralogs to Complement PAX5 Leukemia Driver Mutations 1.17
SLIGRL-induced gene expression changes in NHEK cells 1.17
Loss of Nuclear TDP-43 Is Associated with Decondensation of LINE Retrotransposons [RNA-Seq] 1.17
Loss of Nuclear TDP-43 Is Associated with Decondensation of LINE Retrotransposons 1.17
The landscape of alternative splicing in aggressive prostate cancers 1.17
RNA-sequencing of fibrolamellar carcinoma (FLC) cell line treated with miR-375 mimic 1.17
Targeted inhibition of STAT/TET1 axis as a potent therapeutic strategy for acute myeloid leukemia 1.16
RNA-Sequencing of human dermal lymphatic endothelial cells (HDLEC) treated with siRNA targeting YAP/TAZ and YAP5SA 1.16
Hematopoietic Stem and Progenitor Cells from Human Pluripotent Stem Cells via Transcription Factor Conversion of Hemogenic Endothelium 1.13
Bromodomain inhibition of the co-activators CBP/EP300 facilitates reprogramming (RNA-seq fibroblasts) 1.13
Bromodomain inhibition of the co-activators CBP/EP300 facilitates reprogramming 1.13
RNA profiling Analysis of the Serum Exosomes Derived from Active and Latent M.tuberculosis infectious Patients 1.11
MicroRNA (miR)-211 loss promotes metabolic vulnerability and BRAF inhibitor sensitivity in melanoma 1.11
FOXA1 upregulation promotes enhancer and transcriptional reprogramming in endocrine-resistant breast cancer [RNA-seq] 1.11
FOXA1 upregulation promotes enhancer and transcriptional reprogramming in endocrine-resistant breast cancer 1.11
JAG1 Mediated Notch Signaling Regulates Secretory Cell Differentiation of the Human Airway Epithelium 1.1
Whole transcriptome profile of citrulline-specific B cells from patients with rheumatoid arthritis 1.1
Dynamics of the human and viral m6A RNA methylomes during HIV-1 infection of T cells 1.09
Comparative analysis of kidney organoid and adult human kidney single cell and single nucleus transcriptomes 1.09
MYC dependent mRNA translation shapes gene expression and cell biology 1.09
Single cell RNA sequencing reveals microglia-like cells in cerebrospinal fluid  during virologically suppressed HIV 1.09
5hmC and gene expression data in breast cancer cell lines treated with an antioxidant 1.09
Effect of mitochondria deficiency on senescence-associated gene expression 1.07
Binding to SMN2 pre-mRNA-Protein complex elicits specificity for small molecule splicing modifiers 1.07
Induction and Therapeutic Targeting of Human NPM1c+ Myeloid Leukemia in the Presence of Autologous Immune System in Mice 1.06
Virus Mimicry in the Tumor Microenvironment Activates RIG-I Through Unshielding of Endogenous RNA in Exosomes [RNA-Seq] 1.05
Expression data from human perivascular stem cell-derived extracellular vesicles (PSC-EVs) and PSCs 1.05
The ribosomal prolyl-hydroxylase OGFOD1 decreases during cardiac differentiation, modulates translation and spliceosomal processes 1.04
Identification of a LIF-responsive replication-competent human β cell 1.04
RNA-sequencing time course of Human Intestinal Epithelial Cells (HIECs) following knockdown of miR-30bcd using complementary locked nucleic acids 1.04
Sequencing-based analyses characterize a tumor suppressive role of mir-1271 repressed by DNA hypermethylation in gastric cancer 1.03
Three-dimensional Oxabicycloheptene sulfonate targets the homologous recombination and repair programs through estrogen receptor α antagonism 1.03
Transcriptome analysis reveals malignant and hypoxic signature of glioblastoma 1.03
RNA sequencing of human fibroblasts after SUPT4H1 siRNA treatment 1.02
RNA-sequencing of shSRC-1 and shNT tamoxifen treated LY2 cells 1.02
RNA-sequencing and MeDIP-sequencing of shSRC-1 and shNT tamoxifen treated LY2 cells 1.02
circRNA-sequencing 1.02
RNA-seq of YB5 and MCF7 treated with different doses of decitabine 1.0
RNA sequencing (RNA-SEQ) of EPAS1 knockdown by siRNA in endothelial cells 1.0
MYCi361 regulates MYC target genes 0.99
IGF2BP3 controls cancer cell invasiveness by modulation RISC function 0.98
DNA breaks and chromatin structural changes enhance the transcription of Autoimmune Regulator target genes 0.98
DNA breaks and chromatin structural changes enhance the transcription of Autoimmune Regulator target genes [RNA-Seq] 0.98
Nickel induced transcriptional changes persist post exposure through epigenetic reprograming (RNA-seq dataset) 0.98
Topoisomerase 1 inhibition suppresses inflammatory genes and protects from death by inflammation (RNA-Seq) 0.97
Topoisomerase 1 inhibition suppresses inflammatory genes and protects from death by inflammation 0.97
Gene expression analysis of CD4+ and CD4- ILC1 subsets by RNAseq 0.97
Hypoxic transcriptome of SQ20B human head and neck cancer cells 0.96
Generation and persistence of human tissue-resident memory T cells in lung transplantation 0.96
Comparison of the transcriptome and chromatin state between human cord blood HSC and human iPSC derived hematopoietic progenitor using next-generation sequencing 0.96
microRNAs with an AAGUGC seed motif constitute an integral part of a signaling network driving NSCLC cell proliferation 0.95
ChIPseq and RNAseq analysis of T47D cells with/without silencing TRPS1/CHD4 0.95
Differential gene expression of static and intermittent compressive force treated human periodontal ligament cells 0.95
Isolation and sequencing of AGO-bound RNAs reveals characteristics of stem-loop processing in vivo 0.94
Transcriptome Sequencing of Adipose-Derived Mesechymal Stromal Cells 0.94
miCLIP, RNA-Seq, and Ribo-Seq in MOLM13 cells 0.94
AZ1366: An inhibitor of tankyrase and the canonical Wnt pathway that limits the persistence of non-small cell lung cancer cells following EGFR inhibition 0.94
Cellular acidosis triggers MondoA transcriptional activity by driving mitochondrial ATP production 0.93
Cellular response to hepatitis E virus (HEV) infection 0.92
Targeted degradation of BRD9 reverses oncogenic gene expression in synovial sarcoma [RNA-seq] 0.91
Targeted degradation of BRD9 reverses oncogenic gene expression in synovial sarcoma 0.91
BACH2 in human plasma cell fate decision 0.91
Total RNA deep sequencing (ribosomal depleted) of human umbilical vein endothelial cells exposed to hypoxia (0.2%) for 12h and 24h or kept under normoxic conditions. 0.91
Endothelial gene expression analysis 0.91
MYCL and EP400 are required for Max and MCPyV mediated gene activation 0.91
Trisomy of a ‘Down syndrome critical region’ globally amplifies transcription via HMGN1 overexpression 0.91
RNA-seq analysis reveals profound changes in transcript profiles between siCon- and siH19-transfected uterine smooth muscle cells (USMC) 0.91
Epigenetic Control of Skeletal Development by the Histone Methyltransferase Ezh2 0.91
Human TFIIH kinase CDK7 regulates transcription-associated epigenetic modification 0.91
Transcriptome analysis of fetal Klinefelter testis tissue samples compared to controls 0.9
Splicing and gene expression changes in human mammary epithelial MCF-10A cells expressing SR or SR-like proteins 0.9
RNA-Seq in two Ewing sarcoma cell lines: A673 and SKNMC 0.9
Transcriptional profiles of human blood dendritic cell (DC) subsets at steady state 0.9
Transcriptional profile of CAOV2 ovarian cancer cells with TAZ silencing 0.9
RNAseq of quiescent (Q) and stress induced premature senescent (SIPS) fibroblasts treated with plant extract (1201) from Solidago vigaurea subspecies alpestris 0.9
EPCR Expression Defines the Most Primitive Subset of Human HSPC and Is Required for Their In Vivo Activity 0.89
T47D RNA-seq and ChrRNA-seq data 0.89
Arginine citrullination at the C-terminal domain controls RNA Polymerase II transcription 0.89
MondoA Links Muscle Lipid Accumulation and Insulin Resistance Driven by Nutrient Overload 0.89
Transcriptome profiling in primary human skeletal myotubes with MondoA knockdown 0.89
Global Gene Expression analysis of CUTLL1 cell lines after treatment with Perhexiline 0.88
Mutation independent activation of the Notch pathway is associated with Lapatinib resistance in Her2+ breast cancer cell lines 0.88
Identification of PRMT5-dependent genes in ESA+CD24lowCD44+ MCF7 cells 0.87
Determination of a comprehensive alternative splicing regulatory network and the combinatorial regulation by key factors during Epithelial-to-Mesenchymal Transition [ESRP KD] 0.87
Ultracentifugation and nanoscale deterministic lateral displacement (nanoDLD) of samples for exRNA analysis 0.87
Expression profiling of MCF-7 cells with treatment of TCDD 0.87
Expression profiling of MCF-7 cells with 10nM treatment of TCDD 0.87
Gene expression profiles of rescue with wild type or SUMO double mutant TRIM24 0.86
Systems-level analyses reveal a convergent pathway for progression of diffuse astrocytoma and potential role for resveratrol in delaying high-grade transformation 0.86
Brain organoids reproducibly generate the cellular diversity of the human cerebral cortex 0.85
A TFIID-SAGA perturbation that targets MYB and suppresses acute myeloid leukemia (RNA-seq) 0.85
A TFIID-SAGA perturbation that targets MYB and suppresses acute myeloid leukemia 0.85
siRNA-mediated silencing of ORAI3 in MDA-MB-468 breast cancer cells exposed to hypoxia 0.84
Ebola virus (EBOV) infection of ARPE-19 cells 0.83
RNA polymerase in pre-B-ALL cell lines 0.82
ZEB1 insufficiency causes corneal endothelial cell state transition and altered cellular processing 0.82
Epigenome regulation during epidermal lineage commitment 0.82
Pan-cancer transcriptomic analysis associates long non-coding RNAs with key mutational driver events 0.81
LncRNA NONHSAT113026 represses renal cell carcinoma tumorigenesis through interacting with NF-κB/p50 and SLUG 0.81
Induction of extracellular adenosine salvage and metabolic quiescence regulate the transitional to follicular B cell checkpoint in humans. 0.8
RNA-seq analysis of SKMEL28 melanoma cells following DIRC3 and IGFBP5 ASO knockdown 0.8
Function and hormonal regulation of GATA3 in human first trimester placentation 0.8
RNA-sequencing of the GSI treatment of the CUTLL1 cell line 0.79
CXCR4 regulates extra-medullary myeloma through epithelial-mesenchymal transition-like transcriptional activation 0.79
BCL6 confers KRAS-mutant NSCLCs resistance to BET inhibitors 0.79
HMGA2 Promotes Long-Term Engraftment and Myelo-Erythroid Differentiation of Human Hematopoietic Stem and Progenitor Cells 0.79
Polyol pathway links glucose metabolism to the aggressiveness of cancer cells 0.78
Transcriptomic analysis of acute mitochondrial pyruvate carrier inhibition using UK5099 in ABL prostate cancer cells 0.78
Transcriptomic insights into human decidual and peripheral blood CD8 T cells 0.78
Targeting Taxane-Platin Resistant Lung Cancers with JumonjiC Lysine Demethylase Inhibitors (RNA-Seq) 0.77
Targeting Taxane-Platin Resistant Lung Cancers with JumonjiC Lysine Demethylase Inhibitors 0.77
Genome-wide expression from the esophageal biopsies of subjects with and without eosinophilic esophagitis 0.77
A Hybrid Mechanism of Action for BCL6 in B Cells Defined by Formation of Functionally Distinct Complexes at Enhancers and Promoters 0.76
Luminal lncRNAs Regulation by ERα-controlled Enhancers in a Ligand-independent Manner in Breast Cancer Cells 0.76
RNA-sequencing experiment: Treatment of MCF-7 breast cancer cells with the novel small molecule ZNA 0.75
TT-Seq captures the human transient transcriptome 0.75
Gene expression signatures of innate lymphoid cells from human blood 0.75
Be1 and Be2 B cells are transcriptionally distinct 0.73
RNA-Seq Samples of siTFE3 in 8988T PDA Cell Line to Investigate Transcriptional Control of the Autophagy-Lysosome System 0.72
Developing a Novel Two-Dimensional Culture System to Enrich Human Prostate Luminal Progenitors That Can Function as a Cell of Origin for Prostate Cancer 0.72
Next Generation Sequencing of human SMA and healthy control Motor Neurons 0.72
Transcriptome-wide discovery of microRNA binding sites in human brain by Ago2 HITS-CLIP [Ago2-miRNA-target mRNA complexes] 0.72
RNAseq of CD8+ and CD8- MAIT cells in human peripheral blood 0.72
Single cell analysis of HSV-1 infection reveals anti-viral and developmental programs are activated in distinct sub-populations with opposite outcomes 0.71
MLL-AF4 Spreading Identifies Binding Sites that Are Distinct from Super-Enhancers and that Govern Sensitivity to DOT1L Inhibition in Leukemia. 0.71
Capturing the Interactome of Newly Transcribed RNA (RICK) 0.7
Capturing the Interactome of Newly Transcribed RNA 0.7
The cohesin complex prevents Myc-induced replication stress 0.7
Diffuse Large B Cell Lymphoma cell line with Acquired Resistance to PI3Kδ Inhibitor Idelalisib 0.69
Microvesicle-mediated delivery of miR-1343: impact on markers of fibrosis 0.69
Whole blood stabilization for the microfluidic isolation and molecular characterization of circulating tumor cells 0.68
Anaylsis of the effect of down-regulation of the EWS-FLI1 fusion protein in Ewing Sarcoma cells by RNA-seq. 0.68
Transcriptional study of ARN8 cells treated with novel DHODH inhibitors 0.68
The circadian transcriptional landscape in primary human mammary epithelial cells 0.68
Regulation of DNA methylation landscape in human somatic cell reprogramming by miR-29 family (RNA-seq) 0.68
Regulation of DNA methylation landscape in human somatic cell reprogramming by miR-29 family 0.68
Regulation of stem cell property and drug resistance of cancer cells by targeting transcriptional machinery via inhibition of neddylation 0.67
Gene expression profiles in NORAD knockout and PUMILIO overexpressing cells 0.66
PolyA+ RNA-seq in ALL-SIL upon TLX1 knockdown 0.66
Epithelial-mesenchymal transition and acquired resistance to ALK inhibitors 0.66
Gene expression profiling study by RNA-seq for identifying genes associated with epithelial-mesenchymal transition and acquired resistance to ALK inhibitors 0.66
H3K27Ac in MCF7 Y537S ER mutant cells and RNAseq with and without treatment with THZ1 0.66
CLIC5: a novel ETV6 target gene in childhood acute lymphoblastic leukemia 0.65
The ZZ-type zinc finger of ZZZ3 modulates the ATAC complex-mediated histone acetylation and gene activation 0.63
The hematopoietic master transcription factor PU.1 requires its interaction with the SWI/SNF remodeler to access chromatin de novo 0.62
The hematopoietic master transcription factor PU.1 requires its interaction with the SWI/SNF remodeler to access chromatin de novo [RNA-seq] 0.62
Selective expansion of myeloid and NK cells in humanized mice yields human-like vaccine responses (Experiment 2: scRNA-seq) 0.61
Hyperactive mTOR and MNK1 phosphorylation of eIF4E confer tamoxifen resistance and estrogen independence through selective mRNA translation reprogramming 0.61
RNA sequencing of heart samples of myotonic dystrophic (DM1) patients 0.61
RNA-Seq study of Cell lines rendered resistant to idelalisib and ibrutinib 0.6
Effect of Polybrominated diphenyl ethers (PBDEs) on gene expression of MCF7 cells 0.6
Epithelial-mesenchymal transition markers screenedina cell-based model and validated in lung adenocarcinoma 0.58
Hijacking of stress response machinery by oncogenes in acute leukaemia 0.58
Hijacking of stress response machinery by oncogenes in acute leukaemia [RNA-seq] 0.58
Transcriptomics of human macrophages upon infection with Legionella pneumophila and two isogenic mutants, LamA and AnkH using RNA-seq 0.58
RNA-seq of tumor cells following angiopellosis extravasation 0.58
JMJD1C is required for the survival of acute myeloid leukemia by functioning as a co-activator for key transcription factors 0.58
RNA expression analysis upon JMJD1C depletion 0.58
Regulating Interleukin-2 activity with engineered receptor signaling clamps 0.57
RNA-sequencing of tamoxifen-resistant and -sensitive breast cancer cell lines. 0.56
HEK293 TFAM Knockout Expression Study 0.55
Control of gene expression in senescence through transcriptional read-through of convergent protein-coding genes 0.55
Genome-wide detection of DNase I hypersensitive sites in single cells and FFPE tissue samples 0.55
Comparison of single-cell transcriptomics quality between unfixed cells and cells that were fixed and mock stained according to the RAID procedure 0.54
RNA expression profiling of human mPB or CB-derived CD34+ cells treated with UM171 at different doses 0.54
ATXN7L3 And ENY2 Coordinate Activity Of Multiple H2B Deubiquitinases Important For Cellular Proliferation And Tumor Growth 0.54
ATXN7L3 And ENY2 Coordinate Activity Of Multiple H2B Deubiquitinases Important For Cellular Proliferation And Tumor Growth [RNA-Seq] 0.54
Effect of PRDM11 depletion in U2932 cells 0.54
Whole transcriptome splicing analysis in isogenic lung epithelial and adenocarcinoma cell lines with or without a recurrent splicing factor mutation, U2AF1 (S34F) 0.54
HEXIM1 is induced by DHODH inhibition to suppress melanoma 0.53
HEXIM1 is induced by DHODH inhibition to suppress melanoma [Gro-Seq] 0.53
Genome-wide modelling of transcription kinetics reveals patterns of RNA processing delays 0.53
Small molecule inhibition of ERK dimerization prevents tumorigenesis by Ras-ERK pathway oncogenes 0.52
Recapitulating and Deciphering Tumor-stroma Microenvironment by Using a “LEGO” like 3D printed microfluidic device 0.52
Transcription factor p63 bookmarks genomic loci in epithelial cells and regulates a subset of target genes during epidermal differentiation through dynamic enhancers 0.52
Transcription factor p63 bookmarks genomic loci in epithelial cells and regulates a subset of target genes during epidermal differentiation through dynamic enhancers (RNA-Seq) 0.52
PolyA-sequencing in IMR-32 neuroblastoma cells with shRNA mediated depletion of CDK12, CDK13 or GFP. 0.52
Genome-wide effect of inhibition of glutamine transporter ASCT2 in PC-3 cells by BenSer or GPNA 0.5
The CDK7 Inhibitor THZ1 Alters RNA Polymerase Dynamics at the 5’ and 3’ Ends of Genes 0.5
Cellular recruitment by podocyte-derived pro-migratory factors in assembly of the human renal filter 0.5
RNA-Seq and expression data from human adipose tissue 0.49
Tissue-specific RNA-seq in human evoked inflammation identifies novel blood and adipose lincRNA signatures of cardio-metabolic diseases 0.49
Toxoplasma gondii remodels the cis-regulatory landscape of infected human host cells [RNA-seq] 0.49
Toxoplasma gondii remodels the cis-regulatory landscape of infected human host cells 0.49
Estrogen Receptor Beta Impacts Hormone-Induced Alternative mRNA Splicing in Breast Cancer Cells 0.49
A Stable Transcription Factor Complex Nucleated by Dimeric AML1-ETO Controls Leukaemogenesis 0.49
The Regulation of IFN Type I Pathway Related Genes RSAD2 and ETV7 Specifically Indicate Antibody-Mediated Rejection After Kidney Transplantation 0.49
Potent and targeted activation of HIV-1 using the CRISPR/Cas9 activator Complex 0.48
Gene expression profiling of human iPS cell-derived podocytes and sorted human adult podocytes 0.48
Single-cell analysis reveals stochastic regulation of type I IFN production by plasmacytoid dendritic cells and identifies host-derived environmental cues as amplifier of type I IFN production 0.48
B-cell activating factor (BAFF) stimulation of Burkitt Lymphoma cell line 0.47
B-cell activating factor (BAFF) stimulation of Burkitt Lymphoma cell line [RNA-Seq] 0.47
Enhancer Domains in Gastrointestinal Stromal Tumor Regulate KIT Expression and are Targetable by BET Bromodomain Inhibition [RNA-seq] 0.47
Enhancer Domains in Gastrointestinal Stromal Tumor Regulate KIT Expression and are Targetable by BET Bromodomain Inhibition 0.47
Conservative alteration of chromosomal expression pattern across human solid tumor types 0.47
A combinatorial screen of the CLOUD uncovers a synergy targeting the androgen receptor 0.46
Aberrant downstream mechanisms following loss of KMT2C and KMT2D in Pancreatic Ductal Adenocarcinoma 0.46
Loss of CREBBP results in H3K27Ac loss at enhancers and gene expression repression in lymphoma cells 0.46
Loss of CREBBP results in gene expression repression in lymphoma cells 0.46
KSDM1b Role in Ewing Sarcoma 0.46
DNMT and HDAC inhibitors globally induce cryptic TSSs encoded in long terminal repeats 0.46
Complement protein C1q modulates macrophage molecular signaling and inflammatory responses during ingestion of atherogenic lipoproteins 0.45
SREBP1 drives Keratin 80-dependent cytoskeletal changes and invasive behavior in endocrine resistant ERα breast cancer 0.45
Transcriptome changes due to nuclear penetration of cancer extracellular vesicles 0.45
Integrated analysis of MLL-AF9 AML patients and model leukemias highlights RET and other novel therapeutic targets (RNA-seq AML development) 0.44
Measuring the effect of MYC on transcription during the DNA double-strand break response by RNA-seq of newly synthesized transcripts 0.44
Dnmt3a and Dnmt3b associate with enhancers to regulate human epidermal stem cell homeostasis 0.43
The transcriptome effect of overexpressing EZH2 in MCF7 0.42
TNFα Signaling Exposes Latent Estrogen Receptor Binding Sites in Breast Cancer Cells [GRO-seq] 0.41
TNFα Signaling Exposes Latent Estrogen Receptor Binding Sites in Breast Cancer Cells 0.41
Splicing function of mitotic regulators links R-loop mediated DNA damage to tumor cell killing 0.41
Specific modulation of HIV RNA splicing and upregulation of anti-inflammatory miR-124 by the new drug candidate ABX464 0.41
Isolation and Functional Interrogation of Adult Human Prostate Epithelial Stem Cells at Single Cell Resolution 0.41
RNA-seq expression data from FL-HSPCs after HOXA7 knockdown 0.4
Carcinoma-astrocyte gap junctions promote brain metastasis by cytosolic dsDNA response transfer 0.39
Coronary Artery Disease Associated Transcription Factor TCF21 Regulates Smooth Muscle Precursor Cells that Contribute to the Fibrous Cap 0.39
Self-associated molecular patterns mediate cancer immune evasion by engagement of Siglec receptors 0.38
Mutational landscape of splicing genes and functional consequences across 33 cancer types 0.38
Identification of global XBP1s target gene expression in human prostate cancer cells 0.38
Luminal subtype-specific circRNAs in breast cancer cells by a novel tool for external data analysis. 0.38
α Cell Function and Gene Expression Are Compromised in Type 1 Diabetes 0.37
Newly defined ABCB5+ dermal mesenchymal stem cells promote healing of chronic iron overload wounds via secretion of interleukin-1 receptor antagonist 0.37
Mammalian Hbs1L deficiency causes Pelota depletion and is associated with a unique phenotype 0.37
RNA-seq analysis of primary patient samples to characterize the CNS leukemia 0.37
Transcriptome analysis of CNS leukemia 0.37
RNA-seq of Single-Cell Genotyping of Transcriptomes 0.37
Single-Cell Genotyping of Transcriptomes 0.37
Impact of Escherichia coli K12 and O18 on human platelets: effects on platelet activation, spliced platelet RNAs and proteins 0.37
FBP2 inhibits sarcoma progression by restraining mitochondrial biogenesis 0.36
Functional Importance of eRNAs for Estrogen-dependent Gene Transcriptional Activation 0.36
Expression analysis of PC3 cells treated with scramble AON or AON directed against MBNL1 0.36
Characterization of human ILC2 subsets 0.36
The splicing factor RBM25 controls MYC activity in Acute Myeloid Leukemia 0.35
Next generation sequencing of the transcriptome in MCF-7 cells with/without SRA knockdown 0.35
Osmostress induced changes of chromatin architecture and transcription in mammalian cells [RNA-Seq, HiC] 0.35
Osmostress induced changes of chromatin architecture and transcription in mammalian cells 0.35
Time series single-cell transcriptomic analysis of AEC2 directed differentiation 0.34
Suppression of NAF-1 in Breast Cancer Cells Reduces their Tumorigenicity by Interfering with Cellular Iron Distribution and Metabolism and Ensuing ROS Formation and Apoptosis 0.34
Ribosome profiling of TGFb-treated cells indicates reduced leucine availability 0.34
RNA sequencing of human macrophages treated with iron chelator deferiprone (DEF), with and without lipopolysaccharide (LPS) 0.34
Deletions in the ATAD3 gene cluster cause cerebellar developmental defects with mitochondrial DNA abnormalities owing to local cholesterol insufficiency 0.34
Global Long Terminal Repeat activation participates in establishing the unique gene expression program of classical Hodgkin Lymphoma [Primary RNA-Seq] 0.34
TimeLapse-seq: adding a temporal dimension to RNA sequencing through nucleoside recoding 0.34
RNA-seq on Enasidenib or DMSO Treated CD71+ Cells from Umbilical Cord Blood (UCB) 0.33
Regulation of the glucocorticoid receptor via a BET-dependent enhancer drives antiandrogen resistance in prostate cancer 0.32
Next Generation Sequencing Facilitates Quantitative Analysis of Wild Type and PVT1 Knockdown by CRISPRi in MDA-MB-231 human breast cancer cell line 0.32
Promoter of lncRNA gene *PVT1* is a tumor suppressor DNA element 0.32
A20 regulates canonical wnt-signaling through an interaction with RIPK4 0.32
Identification of Differentially Expressed Splice Variants by the Proteogenomic Pipeline Splicify 0.31
Biomarkers of Cavernous Angioma with Symptomatic Hemorrhage (CASH) [RNA-seq] 0.31
Biomarkers of Cavernous Angioma with Symptomatic Hemorrhage (CASH) 0.31
Total RNA-Seq data from leukemic patients with complex structural variants 0.3
Aberrant expression profile of lncRNA and mRNA in dilated cardiomyopathy by RNA-sequence 0.3
Engineered Nanointerfaces for Microfluidic Isolation and Molecular Profiling of Tumor-specific Extracellular Vesicles 0.3
Differential effects of estrogen receptor beta isoforms on glioblastoma progression 0.29
A monocyte gene expression signature in the early clinical course of Parkinson’s disease 0.29
A genome-wide long noncoding RNA CRISPRi screen identifies PRANCR as a novel regulator of epidermal homeostasis 0.29
Single-cell epigenomics maps the continuous regulatory landscape of human hematopoietic differentiation [bulk RNA-Seq] 0.29
Single-cell epigenomics maps the continuous regulatory landscape of human hematopoietic differentiation 0.29
TT-seq captures simultaneous activation of eRNAs and promoters during T cell activation 0.28
RNA-seq analysis reveals endogenous aryl hydrocarbon receptor regulation is highly associated with eicosanoid synthesis and tumor necrosis factor activity in MCF-7 cancer cells 0.28
Comprehensive Epigenetic Landscape of Rheumatoid Arthritis Fibroblast-like Synoviocytes [RNA-seq] 0.28
Comprehensive Epigenetic Landscape of Rheumatoid Arthritis Fibroblast-like Synoviocytes 0.28
Cystathionine-β-Synthase Promotes Colon Carcinogenesis 0.28
Small-molecule targeting of brachyury transcription factor addiction in chordoma [rnaseq_compound] 0.27
RNA-seq analysis of PRMT5-regulated genes in irradiated/non-irradiated LNCaP cells 0.27
Repression of stress-induced LINE-1 expression protects cancer cell populations from lethal drug-exposures 0.27
Repression of stress-induced LINE-1 expression protects cancer cell populations from lethal drug-exposures [RNA-Seq] 0.27
hnRNP L protects mRNAs from nonsense-mediated mRNA decay 0.26
Aging-associated patterns in the expression of human endogenous retroviruses 0.26
Transcriptional effect of ETV1 knockdown in melanoma cells 0.25
Ewing sarcoma resistance to SP-2509 is not mediated through KDM1A/LSD1 mutation I 0.25
C19ORF66 broadly escapes viral-induced endonuclease cleavage and restricts Kaposi’s Sarcoma Associated Herpesvirus (KSHV) 0.25
A cell cycle-based functional screen to identify lncRNA-based cancer biomarkers 0.23
Transcription factors and stress response gene alterations in human keratinocytes following Solar Simulated Ultra Violet Radiation 0.23
RNA-sequencing of highly pure synovial tissue macrophages reveals two distinct osteoarthritis subgroups that indicate different disease mechanisms. 0.23
Long-term in vitro expansion of epithelial stem cells enabled by pharmacological inhibition of PAK1-ROCK-Myosin II and TGF-β signaling 0.23
Long-term in vitro expansion of epithelial stem cells enabled by pharmacological inhibition of PAK1-ROCK-Myosin II and TGF-β signaling (RNA-seq) 0.23
Transcriptomic analysis of primary human T cells and murine RAW 264.7 macrophages 3D cultured in different collagen densities 0.23
Convergent roles of ATF3 and CSL in chromatin control of CAF activation [RNA-seq] 0.23
Convergent roles of ATF3 and CSL in chromatin control of CAF activation 0.23
Generation of low passage high grade serous ovarian cancer cell lines from primary tumors 0.22
Human MAIT cells exit peripheral tissues and re-circulate via lymph in steady state conditions 0.22
Identification and characterization of circular RNAs as a new class of putative biomarkers in human blood 0.22
Modulation of ESRP2 and MBNL2 in normal kidney and clear cell renal cell carcinoma cell lines for analysis of stability programs 0.21
RNA sequencing data of whole blood cells of normal glucose tolerant (NGT) and gestational diabetes (GDM) pregnant women 0.21
Transcriptome analysis of CD8+ T cells from healthy controls and patients wth CD46 deficiency 0.2
Analysis of transcriptomes of healthy donor and CD46 deficient CD8 T cells 0.2
MEIS2 is a novel oncogenic partner in AML1-ETO positive AML 0.2
MEIS2 is a novel oncogenic partner in AML1-ETO positive AML [RNA-Seq human] 0.2
Compared performance of Affymetrix HTA arrays and Illumina RNAseq for the analysis of tumours [RNA-seq] 0.2
Compared performance of Affymetrix HTA arrays and Illumina RNAseq for the analysis of tumours 0.2
AQP5-Expressing Cells Serve as Stem Cells and Cancer Origins in the Distal Stomach 0.2
TCF21 and Aryl-hydrocarbon receptor gene cooperate to activate a pro-atherosclerotic gene expression program 0.2
Characterisation of the myeloid differentiation process of human hematopoietic stem cells 0.19
MicroRNA-125a-5p overexpression in human macrophages 0.19
Single cell transcriptomics analysis of induced pluripotent stem cell-derived cortical neurons reveals frequent dual layer identity 0.18
p63 controls the enhancer landscape during keratinocyte differentiation 0.18
Clinker: visualizing fusion genes detected in RNA-seq data 0.18
Functional significance of the HIV-1 Tat signature amino acid residues 0.18
Coordinated control of senescence by lncRNA UCA1 and a novel CAPERα/TBX3 co-repressor 0.18
Rate of elongation by RNA polymerase II is influenced by specific gene features and histone modifications 0.18
CD161+ Tconv and Treg share transcriptome and display a migratory phenotype which is modified at the inflamed site 0.17
Ets homologous factor has critical roles in epithelial dysfunction in airway disease [RNA-seq] 0.17
Ets homologous factor has critical roles in epithelial dysfunction in airway disease 0.17
Critical role for Lymphocytes in Producing FLT3LG in Tumors and Driving Checkpoint Therapy-Receptive Immune Microenvironments 0.17
Integrated single cell analysis of blood and cerebrospinal fluid leukocytes in multiple sclerosis 0.17
Direct in vivo evidence for B-cell receptor and NF-KB activation in mantle cell lymphoma: role of the lymph node microenvironment and activating mutations. 0.17
Direct in vivo evidence for B-cell receptor and NF-KB activation in mantle cell lymphoma: role of the lymph node microenvironment and activating mutations. [RNA-Seq] 0.17
PRMT5 Interacts with the BCL6 Oncoprotein and is Required for Germinal Center Formation and Lymphoma Cell Survival 0.17
Germline NLRP1 mutations cause skin inflammatory and cancer susceptibility syndromes via inflammasome activation 0.16
Oncogenic Antisense LncRNA P14AS Regulates Expression of ANRIL through AUF1 Binding 0.16
Effect of BCL11B overexpression on transcriptome of T-cell acute lymphoblastic leukemia (T-ALL) cells 0.16
Transcriptional profile in human S. haematobium infection 0.16
mRNA expression profile of Lymphocytes 0.16
RNAseq transcriptome analysis of White Blood Cells (WBCs) from individuals with and without trisomy 21 [stranded] 0.16
RNA-Seq gene profiling comparison from human cDC subsets and pre-cDC subsets 0.16
Long non-coding RNA profiling of human lymphoid progenitors reveals transcriptional divergence of B cell and T cell lineages 0.15
Characterisation of HIF-dependent alternative isoforms in pancreatic cancer 0.15
Induction of human regulatory innate lymphoid cells from group 2 innate lymphoid cells by retinoic acid 0.15
Trisomy of a ‘Down syndrome critical region’ globally amplifies transcription via HMGN1 overexpression [NALM6 RNA-Seq] 0.15
RNAseq transcriptome analysis of White Blood Cells (WBCs) from individuals with and without trisomy 21 0.15
Prediction of bacterial infection outcome using single cell RNA-seq analysis of human immune cells [sorted population Bulk RNA-seq] 0.15
Transcriptional landscape changes during human embryonic stem cell derivation 0.15
Functional separation of IL7Rα/KLRG1-defined CD8+ T cell populations in humans 0.14
A Basal Stem Cell Signature Identifies Aggressive Prostate Cancer Phenotypes 0.14
RNA sequencing of T-ALL (COG study) 0.14
Analyses of T-ALL (COG study) 0.14
RNAseq of CCRF-CEM, a T-cell acute lymphoblastic leukemia cell line, after knockdown with 2 control hairpins and 6 hairpins targeting the PRC2 complex. 0.14
RNA sequencing of prostate cancer and normal tissue from African Americans and European Americans 0.14
Gene expression in TAL1-driven T-cell ALL in response to TAL1-KD, UTX-KD, and GSKJ4 treatment 0.14
T-cell ALL in response to TAL1-KD, UTX-KD, and GSKJ4 treatment 0.14
PTHrP overexpression in MCF7 cells 0.14
Leucegene: AML sequencing (part 6) 0.13
Preclinical model of obesity and ER-positive breast cancer 0.13
Transcriptome-wide discovery of microRNA binding sites in human brain by Ago2 HITS-CLIP 0.12
Bromodomain protein BRD4 is a transcriptional repressor of autophagy and lysosomal function 0.11
Pseudotime Ordering of Single Human Beta-Cells Reveals States of Insulin Production and Unfolded Protein Response 0.1
Oncogenic roles of ARID5B in T-ALL 0.1
RNA-seq analysis in knockdown Jurkat samples for each factor of TAL1 complex 0.1
Does osteogenic potential of clonal human bone marrow mesenchymal stem/stromal cells correlate with their vascular supportive ability? 0.1
Recurrent alterations of TNFAIP3 (A20) in T-cell large granular lymphocytic leukemia 0.1
single cell RNA-seq from Purkinje cell (ENCSR888LYA) 0.1
Differential YAP expression in glioma cells induces cell competition and promotes tumorigenesis 0.1
Genome-wide mapping of TEL-AML1 targets in acute leukemia 0.1
RNA sequencing and pathway analysis identify important pathways involved in hypertrichosis and intellectual disability in patients with Wiedemann-Steiner syndrome 0.1
HBEC-shp53-PCHD7 0.1
KANK1 inhibits cell growth by inducing apoptosis though regulating CXXC5 in human malignant peripheral nerve sheath tumors 0.09
Priming mobilization of hair follicle stem cells triggers permanent loss of regeneration after alkylating chemotherapy 0.09
Epigenomes and transcriptomes of human monocytes before and after in vivo exposure to Bacillus Calmette-Guérin vaccine 0.09
Role of SUMOylation in differential ERα transcriptional repression by SERMs and pure antiestrogens in breast cancer cells 0.08
Single-cell survey of human lymphatics unveils marked endothelial cell heterogeneity and mechanisms of homing for neutrophils 0.08
Pre-clinical evaluation of cysteamine bitartrate as a therapeutic agent for mitochondrial respiratory chain disease 0.08
Pre-clinical evaluation of cysteamine bitartrate as a therapeutic agent for mitochondrial respiratory chain disease (human) 0.08
Epigenetic reprogramming of immune cells in women with PCOS impact genes controlling reproductive function [RNAseq] 0.08
Epigenetic reprogramming of immune cells in women with PCOS impact genes controlling reproductive function 0.08
Exploiting Prmt5-orchestrated intron detention signatures to treat splicing-addicted malignant glioma tumors 0.08
Gene expression profiling in follicular lymphoma (FL) samples and paired transformed follicular lymphoma (tFL) (n=6 samples) 0.07
The serine hydroxymethyltransferase-2 (SHMT2) initiates lymphoma development through epigenetic tumor suppressor silencing. 0.07
Human Tfh cell RNA bulk sequencing 0.06
LIN28A modulates splicing and gene expression programs in breast cancer cells [RNA-Seq] 0.06
LIN28A modulates splicing and gene expression programs in breast cancer cells 0.06
RNAseq of Extracellular vesicle RNAs and cellular RNAs from HPASMCs with or without TGF-b1 or BMP4 treatment 0.06
Aging Human Hematopoietic Stem Cells Manifest Profound Epigenetic Reprogramming of Enhancers That May Predispose to Leukemia (RNA-Seq of HSCe) 0.06
Innate Immune Landscape in Early Lung Adenocarcinoma by Paired Single-Cell Analyses 0.06
quanTIseq: quantifying immune contexture of human tumors 0.06
Novel Transcriptional Activity and Extensive Allelic Imbalance in the Human MHC Region 0.06
MeRIP-seq for heat shock in B-cell lymphoma cells 0.05
Combined MEKi (GDC-0973) and WNT (G007-LK) treatment in APC and KRAS mutant HCT-15 cell line 0.04
Expression analysis of the TAF1 syndrome 0.03
Histone demethylase LSD1 is required for germinal center formation and BCL6 driven lymphomagenesis 0.03
Transcriptional changes in lymphoma cells induced by LSD1 depletion 0.03
Genome Wide Chromatin Mapping of accessibility (ATAC-seq) and H3K27ac histone modifications in CD56bright and CD56dim natural killer cells 0.03
RNA sequencing of bone marrow CD34+ cells from myelodysplastic syndrome patients with and without SF3B1 mutation and from healthy controls 0.03
Enhancer Activation Requires Trans-Recruitment of a Mega Transcription Factor Complex 0.03
Enhancer Activation Requires Trans-Recruitment of a Mega Transcription Factor Complex (Gro-seq) 0.03
RNA-seq of exosomes identifies lncRNA profiles that distinguish early-stage esophageal squamous cell carcinoma (ESCC) from non-malignant esophagitis 0.02
Genome-wide DNA hypomethylation and RNA:DNA hybrid accumulation in Aicardi-Goutières syndrome 0.02
YY1 haploinsufficiency causes an intellectual disability syndrome featuring transcriptional and chromatin dysfunction [RNA-seq] 0.02
YY1 haploinsufficiency causes an intellectual disability syndrome featuring transcriptional and chromatin dysfunction. 0.02
ARID1A is a critical regulator of luminal identity and therapeutic response in oestrogen receptor-positive breast cancer (RNA-Seq) 0.02
Parallel T-cell cloning and deep sequencing of the transcripts of human MAIT cells reveal stable oligoclonal TCRβ repertoire 0.01
IMP3 regulated gene expression in breast cancer cells 0.01
The p30 isoform of CEBPA uncovers a silent enhancer to drive the expression of the tumor promotive factor CD73 in CEBPA mutant AML 0.01
Low-dose decitabine priming endows CAR T cells with enhanced and persistent anti-tumor potential by epigenetic reprogramming 0.01
Interaction between mitoNEET and NAF-1 in cancer cells 0.0
Analysis of an artificial zinc finger epigenetic modulator: widespread binding but limited regulation 0.0


Contact Us

For scientific and technical queries contact Butte Lab @UCSF


Cite GENEVA Tool

Manuscript in Preparation